Release
FDA Approves a Second Weekly Basal Insulin Option for Type 2 Diabetes
JAMA ·
The Brief
- The US FDA approved another once-weekly basal insulin injection for adults with type 2 diabetes.
- The approval adds a second weekly basal insulin option for this patient group.
- The story is reported by JAMA, dated 2026-11-10.
Why it matters
Weekly basal insulin could reduce injection frequency for adults with type 2 diabetes, which may matter for adherence and clinical practice.
Who’s affected
- adults with type 2 diabetes
- clinicians who prescribe basal insulin
- patients and caregivers managing insulin therapy
- #diabetes
- #insulin
- #fda
- #drug approval
- #type 2 diabetes
The US Food and Drug Administration (FDA) approved another once-weekly basal insulin injection for adults with type 2 diabetes.
Timeline
FDA approval of a second once-weekly basal insulin for type 2 diabetes reported by JAMA
JAMA Current Issue
FDA Approves a Second Weekly Basal Insulin Option for Type 2 Diabetes